All News

Men with advanced prostate cancer had similar survival with intermittent or continuous androgen deprivation therapy, pooled data from two randomized trials showed.

The use of voided midstream urine cultures in diagnosing cystitis has limited value but can be modified to avoid undertreatment and inappropriate treatment, according to a recently published study.

Data are lacking to recommend for or against the use of vitamins, minerals, and multivitamin supplements for the prevention of cancer and cardiovascular disease, according to a new U.S. Preventive Services Task Force draft recommendation statement.

An investigational minimally invasive device was found safe and effective in limiting rapid pressure changes within the bladder to reduce symptoms of stress urinary incontinence, the authors of a recently published trial reported.

No differences in body composition were found among metastatic castration-resistant prostate cancer patients taking abiraterone acetate (ZYTIGA), enzalutamide (Xtandi), or placebo who were treated as part of two clinical trials.

"Training more urologists is a long-term plan that’s needed, but PAs/NPs aren’t a solution everywhere because the distribution of specialists can vary, even within the same state."

With such an overwhelming number of choices, it can be daunting to find apps that have practical use for urologists or their patients, and also work well. In this article, I provide some direction and references to help you find the right app for your purpose.

A relatively simple technique called the spousal lifetime access trust has proven especially advantageous and popular among those who have remarried and want to provide for children from a prior marriage.

If you’re in private practice, your profits will be directly affected by how your staff can manage and adapt to ACA-related coverage changes.

In this column, we outline the issues that we know will be important in 2014 and discuss what we think might be implemented by Medicare for 2014.

Urologists Alexander Kutikov, MD, and Todd M. Morgan, MD, discuss the impetus behind UrologyMatch.com and drawMD and how they benefit physicians and patients.

It appears that Congress is finally determined to provide a permanent solution to the annual Medicare fee payment crisis, and there is a possibility that the process also could reduce pressure to end an exception to the Stark self-referral law upon which many urologists have come to rely.

Renacidin Irrigation (Citric Acid, Glucono delta-Lactone, and Magnesium Carbonate) is once again available after a series of manufacturing issues resulted in the product being unavailable for over a year, according to United-Guardian, Inc., the product’s marketer.

The American College of Surgeons, in collaboration with the AUA and 14 other specialty surgical organizations, has jointly published and released the seventh edition of a report that provides guidance on how often an operation might require the use of a physician as an assistant.

Of top concern to urologists are declining reimbursement (88%), increasing government regulations (86%), Obamacare (73%), and increasing overhead (71%). This finding-from the most recent Urology Times State of the Specialty survey-was consistent for all ages, practice types, and practice sizes.

Among a group of men who underwent coronary angiography and had a low serum testosterone level, the use of testosterone therapy was associated with increased risk of death, heart attack, or ischemic stroke, according to a recent study.

Prostate cancer has made its way into another set of Choosing Wisely recommendations, this time from the American Society of Clinical Oncology.

Fewer than 10% of patients are being told about the possibility of overdiagnosis and overtreatment as a result of screening for prostate and other cancers, according to findings from a recently published survey.

Among patients with kidney stones, shared medical appointments decrease appointment wait times, increase patient knowledge about stone prevention, and lead to high levels of patient satisfaction, researchers from the University of Wisconsin, Madison reported.

Uroplasty announced that Humana, Inc. has written a positive coverage policy for percutaneous tibial nerve stimulation delivered via its Urgent PC Neuromodulation System.

Men with short-ended chromosomes in the immune cells in their blood appear to be at increased risk for aggressive prostate cancer compared with men with long-ended chromosomes, according to findings from a recent study.

A study of several hundred chemicals used in commercial pesticides has found only weak evidence that any of them are associated with hypospadias, the authors reported.

Much of what is said by critics of the RUC process is at best incorrect and at worst purposely misstated.

The FDA has approved a product label addition for the phosphodiesterase-type-5 inhibitor tadalafil (Cialis) that involves its use with finasteride (Proscar).

Urology drugs and devices in the pipeline from AltheRx Pharmaceuticals, TARIS Biomedical, AstraZeneca, NxThera, NovaBay Pharmaceuticals, and OncoGenex Pharmaceuticals.

Energized by recent legislative victories from Tallahassee to Olympia, urologists looked to the future as they gathered for the 6th annual AACU State Society Network Advocacy Conference. Taking place just days after the Oct. 1 launch of open enrollment for health insurance exchange plans, the event focused on the role of urologists and their professional associations in a transformed health care delivery system.

The latest products and services from SuperSonic Imagine, Auxilium Pharmaceuticals, VIVUS, the Centers for Medicare & Medicaid Services, Innovus Pharmaceuticals, Buffalo Filter, KRS Global Biotechnology, Demos Health, and Ethicon Endo-Surgery.

A phase III trial of enzalutamide (Xtandi) in chemotherapy-naïve patients with advanced prostate cancer has met both of its primary endpoints in an interim analysis, and the trial will be stopped early due to the drug’s benefit.